Thursday, April 23, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

Where are the Physician Investors?

They come in all shapes and sizes

Arlen Meyers by Arlen Meyers
February 25, 2024
in Financial Markets
0
Where are the Physician Investors

Airfocus

Physician entrepreneurs come in many assorted flavors, like technopreneurs, social entrepreneurs, intrapreneurs and consultant/freelancer/service providers. Another role they play in the medical innovation supply chain is as a physician investor. Like any other investor, they use different platforms to achieve their financial goals, using mutual fund portfolios, investing as an angel, or participating in angel networks or investment syndicates.

A more recent trend is doctors becoming investment bankers or venture capital general or limited partners, consultants and advisors.

Many biomedical and clinical startups target health professionals for early seed stage investment. However, the doctor funded startup comes with some baggage and risks beyond the unusual ones.

If you are considering raising money from doctors, dentists, nurses, pharmacists or other health professionals, here are some tips:

  1. As an outsider (non-MD or medical professional degree holder) , it is difficult sometimes to be a trusted member of the inner sanctum, particularly when others think you are only there to get their money. Relationships take time to develop, time you might not have as your burn rate meter is running out. Be strategic and honest but focus on the few investors who show a genuine interest. Even better, develop the networks beforehand so you have some comfort level when it’s time to make the ask.
  2. Find a reputable navigator, mentor, connector, or maven to introduce you those who might have an interest in your idea based on previous investment history or record of accomplishment
  3. Do your homework on national angel networks that specialize in biomedical clinical or digital health investments and are composed of members in the health professions. Some specialize in creating investor networks that include just doctors investing in ideas from other doctors. Check www.angelcapitalassociation.org or www.gust.com or www.ii4change.com (Tell them SoPE (The Society of Physician Entrepreneurs) sent you)
  4. Some doctors are angels, investment bankers or work with private equity firms or advise family offices, so expand your universe of sources as part of your research. Secondary sources might include wealth managers or others in the financial services industry.
  5. Join and participate in interdisciplinary, eclectic regional innovation ecosystems where you are more likely to meet and interact with investor physicians.
  6. Go where the money is. Many physician investors like to stay off the radar. Some, on the other hand, make their investment propensities more public. You might find more success in vacation, or second home communities or social events supported by high-net-worth individuals
  7. Attend hospital or community resource fundraisers to show your support and find a seat next to your new investor. Consider college alumni events as another way to link. Get more involved in voluntary activities.
  8. Find companies like yours that were able to raise money in early seed rounds from doctors. Contact the CEO and pick their brains for tips on technique and ways to access their network.
  9. Be sure your investment pitch is ready for prime time since you will only have one chance to make a first impression. Here are the biggest reasons why it might not be. You never know when and where you might meet your next investor, doctor or not.
  10. Be sure you understand the issues around raising private money and the impact of recent equity-crowdfunding regulations. Talk to your legal and accounting advisors and plan.

Many people think that doctors are willing and eager to give you their money because 1) they have a firm understanding of the clinical challenge you are trying to solve or the opportunity you are trying to pursue, 2) they are savvy investors or 3) they have networks and connections and can help spread the word and create buzz around your idea. Think again. While I vigorously disagree with the conventional wisdom that “doctors are lousy business people”, in most cases they are like every other investor who is looking for the quickest return on investment with commensurate risk. Connecting and building a trusted relationship is the first step. Success or failure sits on that foundation.

Source: Arlen Meyers MD MBA Substack
ShareTweet
Arlen Meyers

Arlen Meyers

Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs on Substack.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • National Opioid Settlement Injunction

    National Opioid Settlement Injunction

    1 shares
    Share 0 Tweet 0
  • Strategies for Transitioning Off GLP-1 Injections

    1 shares
    Share 0 Tweet 0
  • Biosimilar Economics Through a Benchmark Lens: What WAC and NADAC Reveal About Competition

    0 shares
    Share 0 Tweet 0
  • PBMs as Price Signal Absorbers: How Formulary Architecture Distorts Benchmark Data

    0 shares
    Share 0 Tweet 0
  • The IRA’s Negotiation Mechanism and What Benchmark Data Will Reveal About Its Actual Effect

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy